Nordisk Pharma ApS — Credit Rating and Financial Key Figures

Nordisk Pharma ApS (CVR number: 42852287) is a company from VALLENSBÆK. The company recorded a gross profit of 552.9 kDKK in 2024. The operating profit was 552.9 kDKK, while net earnings were 425.5 kDKK. The profitability of the company measured by Return on Assets (ROA) was 53.8 %, which can be considered excellent and Return on Equity (ROE) was 53.4 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 77.2 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. Nordisk Pharma ApS's liquidity measured by quick ratio was 4.2 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.